Perkins D
Melbourne School of Population and Global Health, The University of Melbourne, Parkville, VIC, Australia. d.perkins@unimelb.edu.au.
ArticleDMT
Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.
ArticleDMT
DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers.
ArticleAyahuasca
A new insight into ayahuasca's adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS).
ArticlePsilocybin
Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement.
ArticleAyahuasca
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.
ArticleKetamine
Ketamine's Altered States Meta-Analysis: The Relationship Between Psychomimetic and Clinical Effects With Focus in Depression.
ArticleAyahuasca
Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset.
ArticlePsilocybin
Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.
ArticlePsilocybin
Artificial intelligence and psychedelic medicine.
ArticleAyahuasca
Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review.
ArticlePsilocybin
Drug-drug interactions involving classic psychedelics: A systematic review.
ArticleAyahuasca
Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.
PreprintPsilocybin
Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review
ArticlePsilocybin
Default Mode Network Modulation by Psychedelics: A Systematic Review.
PreprintAyahuasca
Ayahuasca – a review of historical, pharmacological, and therapeutic aspects
ArticleAyahuasca
Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use.
ArticleAyahuasca
Moderators of ayahuasca's biological antidepressant action.
ArticleAyahuasca
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey.
ArticleAyahuasca
Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior.
ArticleAyahuasca
Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.
ArticlePsilocybin
Psychedelic medicines for mood disorders: current evidence and clinical considerations.
ArticleAyahuasca
Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.
ArticlePsilocybin
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
ArticlePsilocybin